JBM  Vol.7 No.7 , July 2019
Morinda citrifolia (Noni) Fruit Juice Inhibits Endocannabinoid Degradation Enzymes
Abstract: Morinda citrifolia (noni) fruit juice has been shown to have a wide variety of potential health benefits in human clinical trials. It may also influence the endocannabinoid system of the body. Since the main ingredient of the product studied in these clinical trials was juice made from noni fruit puree from French Polynesia, it was evaluated for its ability to inhibit the two major endocannabinoid degradation enzymes in vitro. Noni fruit juice inhibited both fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) in a concentration-dependent manner, suggesting that it may help maintain anandamide and 2-arachidonoylglycerol levels. Samples of the puree were also analyzed for the presence of characteristic phytochemical markers of authentic noni fruit such as scopoletin, rutin, quercetin, deacetylasperulosidic acid and asperulosidic acid, all of which were present. Also present was scandoside, which is reported for the first time as being identified in noni fruit or its juice. Some of these compounds may contribute to the FAAH and MAGL inhibiting activity of noni juice. These results reveal another set of mechanisms by which noni juice possibly supports mental health, maintains joint health, relieves discomfort and modulates the immune system.
Cite this paper: West, B. , Deng, S. and Jensen, C. (2019) Morinda citrifolia (Noni) Fruit Juice Inhibits Endocannabinoid Degradation Enzymes. Journal of Biosciences and Medicines, 7, 22-34. doi: 10.4236/jbm.2019.77003.

[1]   Pacher, P., Bátkai, S. and Kunos G. (2006) The Endocannabinoid System as an Emerging Target of Pharmacotherapy. Pharmacological Reviews, 58, 389-462.

[2]   Bab, I. and Zimmer, A. (2008) Cannabinoid Receptors and the Regulation of Bone Mass. British Journal of Pharmacology, 153, 182-188.

[3]   Borowska, M., Czarnywojtek, A., Sawicka-Gutaj, N., Wolinski, K., Plazinska, M.T., Mikolajczak, P. and Ruchala, M. (2018) The Effects of Cannabinoids on the Endocrine System. Endokrynologia Polska, 69, 705-719.

[4]   Eid, B.G. (2019) Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle. Journal of Microscopy and Ultrastructure, 6, 171-176.

[5]   Lu, H.C. and Mackie, K. (2016) An Introduction to the Endogenous Cannabinoid System. Biological Psychiatry, 79, 516-525.

[6]   Howlett, A.C. and Abood, M.E. (2017) CB1 and CB2 Receptor Pharmacology. Advances in Pharmacology, 80, 169-206.

[7]   West, B.J., Jensen, C.J., Westendorf, J. and White, L.D. (2006) A Safety Review of Noni Fruit Juice. Journal of Food Science, 71, R100-R106.

[8]   Morton, J. (1992) The Ocean-Going Noni, or Indian Mulberry (Morinda citrifolia, Rubiaceae) and Some of Its “Colorful” Relatives. Economic Botany, 46, 241-256.

[9]   Whistler, W.A. (1992) Polynesian Herbal Medicine. National Tropical Botanical Garden, Hong Kong.

[10]   Petard, P. (1986) Quelques Plantes Utiles de Polynesie Francaise et Raau Tahiti. Editions Haere Po No Tahiti, Papeete.

[11]   Brown, F.B.H. (1935) Flora of Southeastern Polynesia. III. Dicotyledons. Bishop Museum, Honolulu, HI.

[12]   Girardi, C., Butaud, J.F., Ollier, C., Ingert, N., Weniger, B., Raharivelomanana, P. and Moretti, C. (2015) Herbal Medicine in the Marquesas Islands. Journal of Ethnopharmacology, 161, 200-213.

[13]   West, B.J., Deng, S., Isami, F., Uwaya, A. and Jensen, C.J. (2018) The Potential Health Benefits of Noni Juice: A Review of Human Intervention Studies. Foods, 7, 58.

[14]   Palu, A.K., Kim, A.H., West, B.J., Deng, S., Jensen, J. and White, L. (2008) The Effects of Morinda citrifolia L. (Noni) on the Immune System: Its Molecular Mechanisms of Action. Journal of Ethnopharmacology, 115, 502-506.

[15]   European Commission (2003) Commission Decision of 5 June 2003 Authorising the Placing on the Market of “Noni Juice “(Juice of the Fruit of Morinda citrifolia L.) as a Novel Food Ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council. Official Journal of the European Union L, 144, 12.

[16]   European Commission (2003) Commission Decision of 21 April 2010 Authorising the Placing on the Market of Puree and Concentrate of the Fruits of Morinda citrifolia as a Novel Food Ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council. Official Journal of the European Union L, 102, 49-51.

[17]   Deng, S., West, B.J., Palu, A.K. and Jensen, C.J. (2011) Determination and Comparative Analysis of Major Iridoids in Different Parts and Cultivation Sources of Morinda citrifolia. Phytochemical Analysis, 22, 26-30.

[18]   Deng, S., West, B.J. and Jensen, C.J. (2010) A Quantitative Comparison of Phytochemical Components in Global Noni Fruits and Their Commercial Products. Food Chemistry, 122, 267-270.

[19]   Yang, J., Paulino, R., Janke-Stedronsky, S. and Abawi, F. (2007) Free Radical Scavenging Activity and Total Phenols of Noni (Morinda citrifolia L.) Juice and Powder in Processing and Storage. Food Chemistry, 102, 302-308.

[20]   El-Alfy, A.T., Joseph, S., Brahmbhatt, A., Akati, S. and Abourashed, E.A. (2016) Indirect Modulation of the Endocannabinoid System by Specific Fractions of Nutmeg Total Extract. Pharmaceutical Biology, 54, 2933-2938.

[21]   Wang, M.Y., Peng, L., Lutfiyya, M.N., Henley, E., Weidenbacher-Hoper, V. and Anderson, G. (2009) Morinda citrifolia (Noni) Reduces Cancer Risk in Current Smokers by Decreasing Aromatic DNA Adducts. Nutrition and Cancer, 61, 634-639.

[22]   Wang, M.Y., Peng, L., Weidenbacher-Hoper, V., Deng, S., Anderson, G. and West, B.J. (2012) Noni Juice Improves Serum Lipid Profiles and Other Risk Markers in Cigarette Smokers. The Scientific World Journal, 2012, Article ID: 594657.

[23]   Zygmunt, P.M., Ermund, A., Movahed, P., Andersson, D.A., Simonsen, C., Jönsson, B.A., Blomgren, A., Birnir, B., Bevan, S., Eschalier, A., Mallet, C., Gomis, A. and Högestätt, E.D. (2013) Monoacylglycerols Activate TRPV1—A Link between Phospholipase C and TRPV1. PLoS ONE, 8, e81618.

[24]   Piomelli, D. and Sasso, O. (2014) Peripheral Gating of Pain Signals by Endogenous Analgesic Lipids. Nature Neuroscience, 17, 164-174.

[25]   Sharir, H. and Abood, M.E. (2010) Pharmacological Characterization of GPR55, a Putative Cannabinoid Receptor. Pharmacology & Therapeutics, 126, 301-313.

[26]   Cary, L.M., Slivicki, R.A., Leishman, E., Cornett, B., Mackie, K., Bradshaw, H. and Hohmann, A.G. (2016) A Pro-Nociceptive Phenotype Unmasked in Mice Lacking Fatty-Acid Amide Hydrolase. Molecular Pain, 12, 1-23.

[27]   Kim, M.J., Tanioka, M., Um, S.W., Hong, S.K. and Lee, B.H. (2018) Analgesic Effects of FAAH Inhibitor in the Insular Cortex of Nerve-Injured Rats. Molecular Pain, 14, 1-26.

[28]   Ignatowska-Jankowska, B., Wilkerson, J.L., Mustafa, M., Abdullah, R., Niphakis, M., Wiley, J.L., Cravatt, B.F. and Lichtman, A.H. (2015) Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice. The Journal of Pharmacology and Experimental Therapeutics, 353, 424-432.

[29]   Adamson Barnes, N.S., Mitchell, V.A., Kazantzis, N.P. and Vaughan, C.W. (2016) Actions of the Dual FAAH/MAGL Inhibitor JZL195 in a Murine Neuropathic Pain Model. British Journal of Pharmacology, 173, 77-87.

[30]   Basar, S., Uhlenhut, K., Högger, P., Schöne, F. and Westendorf, J. (2010) Analgesic and Anti-Inflammatory Activity of Morinda citrifolia L. (Noni) Fruit. Phytotherapy Research, 24, 38-42.

[31]   Kapellos, T.S., Recio, C., Greaves, D.R. and Iqbal, A.J. (2017) Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of Endotoxemia. Mediators of Inflammation, 2017, Article ID: 4315412.

[32]   Bian, Q., Wang, Y.J., Liu, S.F. and Li, Y.P. (2012) Osteoarthritis: Genetic Factors, Animal Models, Mechanisms, and Therapies. Frontiers in Bioscience, E4, 74-100.

[33]   Karadimas, S.K., Klironomos, G., Papachristou, D.J., Papanikolaou, S., Papadaki, E. and Gatzounis, G. (2013) Immunohistochemical Profile of NF-κB/p50, NF-κB/p65, MMP-9, MMP-2, and u-PA in Experimental Cervical Spondylotic Myelopathy. Spine, 38, 4-10.

[34]   Akinbo, S.R.A., Noronha, C.C., Okanlawon, A.O. and Denesi, M.A. (2006) Comparative Study of the Effect of Morinda citrifolia (Noni) with Selected Physiotherapy Modalities in the Management of Patients with Cervical Spondylosis. Nigerian Journal of Health and Biomedical Sciences, 5, 6-11.

[35]   Wang, M.Y., Lutfiyya, M.N., Weidenbacher-Hoper, V., Peng, L., Lipsky, M.S. and Anderson, G. (2011) Morinda citrifolia L. (Noni) Improves the Quality of Life in Adults with Osteoarthritis. Functional Foods in Health & Disease, 1, 75-90.

[36]   La Porta, C., Bura, S.A., Negrete, R. and Maldonado, R. (2014) Involvement of the Endocannabinoid System in Osteoarthritis Pain. European Journal of Neuroscience, 39, 485-500.

[37]   Morena, M., Patel, S., Bains, J.S. and Hill, M.N. (2016) Neurobiological Interactions Between Stress and the Endocannabinoid System. Neuropsychopharmacology, 41, 80-102.

[38]   Langford, J., Doughty, A., Wang, M., Clayton, L. and Babich, M. (2004) Effects of Morinda citrifolia on Quality of Life and Auditory Function in Postmenopausal Women. Journal of Alternative and Complementary Medicine, 10, 737-739.

[39]   Bayo, N.O., Eyarefe, O.D. and Arowolo, R.O.A. (2010) Effects of Tahitian Noni Juice on Ketamine Anaesthesia in Some Local Rabbits. British Journal of Pharmacology and Toxicology, 1, 81-84.

[40]   Muto, J., Hosung, L., Uwaya, A., Isami, F., Ohno, M. and Mikami, T. (2010) Morinda citrifolia Fruit Reduces Stress-Induced Impairment of Cognitive Function Accompanied by Vasculature Improvement in Mice. Physiology and Behavior, 101, 211-217.

[41]   Hill, M.N., Kumar, S.A., Filipski, S.B., Iverson, M., Stuhr, K.L., Keith, J.M., Cravatt, B.F., Hillard, C.J., Chattarji, S. and McEwen, B.S. (2013) Disruption of Fatty Acid Amide Hydrolase Activity Prevents the Effects of Chronic Stress on Anxiety and Amygdalar Microstructure. Molecular Psychiatry, 18, 1125-1135.

[42]   Kishimoto, Y., Cagniard, B., Yamazaki, M., Nakayama, J., Sakimura, K., Kirino, Y. and Kano, M. (2015) Task-Specific Enhancement of Hippocampus-Dependent Learning in Mice Deficient in Monoacylglycerol Lipase, the Major Hydrolyzing Enzyme of the Endocannabinoid 2-Arachidonoylglycerol. Frontiers in Behavioral Neuroscience, 9, 134.

[43]   Thors, L., Belghiti, M. and Fowler, C.J. (2008) Inhibition of Fatty Acid Amide Hydrolase by Kaempferol and Related Naturally Occurring Flavonoids. British Journal of Pharmacology, 155, 244-252.

[44]   Deng, S., Palu, A.K., West, B.J., Su, C.X., Zhou, B.N. and Jensen, J.C. (2007) Lipoxygenase Inhibitory Constituents of the Fruits of Noni (Morinda citrifolia) Collected in Tahiti. Journal of Natural Products, 70, 859-862.

[45]   Urquhart, P., Nicolaou, A. and Woodward, D.F. (2015) Endocannabinoids and Their Oxygenation by Cyclo-Oxygenases, Lipoxygenases and Other Oxygenases. Biochimica et Biophysica Acta, 1851, 366-376.

[46]   Wang, M.Y., West, B.J., Jensen, C.J., Nowicki, D., Su, C., Palu, A.K. and Anderson, G. (2002) Morinda citrifolia (Noni): A Literature Review and Recent Advances in Noni Research. Acta Pharmacologica Sinica, 23, 1127-1141.

[47]   Xu, J., McSloy, A.C., Anderson, B.K., Godbee, R.G., Peek, S.F. and Darien, B.J. (2006) Tahitian Noni® Equine EssentialsTM: A Novel Anti-Inflammatory and a COX-2 Inhibitor Which Regulates LPS-Induced Inflammatory Mediator Expression in Equine Neonatal Monocytes. Journal of Veterinary Internal Medicine, 20, 756.

[48]   Muralidharan, P. and Srikanth, J. (2010) Anti Epileptic Activity of Morinda citrifolia Linn Fruit Extract. E-Journal of Chemistry, 7, 612-616.

[49]   Neubauer, D., Perkovic Benedik, M. and Osredkar, D. (2018) Cannabidiol for Treatment of Refractory Childhood Epilepsies: Experience from a Single Tertiary Epilepsy Center in Slovenia. Epilepsy & Behavior, 81, 79-85.

[50]   Watanabe, K., Ogi, H., Nakamura, S., Kayano, Y., Matsunaga, T., Yoshimura, H. and Yamamoto, I. (1998) Distribution and Characterization of Anandamide Amidohydrolase in Mouse Brain and Liver. Life Sciences, 62, 1223-1229.

[51]   De Petrocellis, L., Ligresti, A., Moriello, A.S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C.G. and Di Marzo, V. (2011) Effects of Cannabinoids and Cannabinoid-Enriched Cannabis Extracts on TRP Channels and Endocannabinoid Metabolic Enzymes. British Journal of Pharmacology, 163, 1479-1494.

[52]   Pawlus, A.D. and Kinghorn, D.A. (2007) Review of the Ethnobotany, Chemistry, Biological Activity and Safety of the Botanical Dietary Supplement Morinda citrifolia (Noni). The Journal of Pharmacy and Pharmacology, 59, 1587-1609.

[53]   Beladjila, K.A., Berrehal, D., De Tommasi, N., Granchi, C., Bononi, G., Braca, A. and De Leo, M. (2018) New Phenylethanoid Glycosides from Cistanche phelypaea and Their Activity as Inhibitors of Monoacylglycerol Lipase (MAGL). Planta Medica, 84, 710-715.